Ptc Therapeutics (PTCT) Net Margin Growth (1y) (2013 - 2026)

Ptc Therapeutics (PTCT) Net Margin Growth (1y) (2013 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin Growth (1y) (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1,491.00
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 1,120.00
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -653.00
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 447.00
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Ptc Therapeutics 6.47 Bn 4.58 Bn 244.52 Mn -7,471.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -7,471.00
Dec 31, 2025 -4,523.00
Sep 30, 2025 6,173.00
Mar 31, 2025 11,726.00
Dec 31, 2024 1,983.00
Sep 30, 2024 1,345.00
Mar 31, 2024 1,947.00
Dec 31, 2023 5,134.00
Sep 30, 2023 -1,730.00
Jun 30, 2023 -114.00
Mar 31, 2023 2,215.00
Dec 31, 2022 -1,537.00
Sep 30, 2022 4,596.00
Jun 30, 2022 957.00
Mar 31, 2022 2,387.00
Dec 31, 2021 -46,801.00
Sep 30, 2021 -3,745.00
Jun 30, 2021 13,968.00
Mar 31, 2021 5,602.00
Dec 31, 2020 18,003.00